source
- Takeda, Regeneron, Sanofi and Bristol Myers Squibb announce pipeline cuts in quarterly updatesTakeda, Regeneron, Sanofi and Bristol Myers Squibb disclosed that they are trimming several drug development programs as part of their recent earnings releases. The cuts affect a mix of early‑stage…
- Legend Biotech CEO Ying Huang resigns abruptly, board taps interim leaderLegend Biotech announced that its chief executive, Dr. Ying Huang, has stepped down unexpectedly, leaving the role vacant. Huang, who moved from chief financial officer to CEO in 2020 after a cust…